Evidence map›Paper›PMID 29237288›Full record

ArticleJournal of diabetes science and technology2018

The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System.

Elias K Spanakis, David L Levitt, Tariq Siddiqui, Lakshmi G Singh, Lillian Pinault, John Sorkin, Guillermo E Umpierrez, Jeffrey C Fink

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04230694 nacompletednot on this mapstarted 2021, after this paper: background citation

Continuous Glucose Monitoring of Hospitalized Patients With Diabetes: A Pilot Study to Establish Evidence

TypeinterventionalSponsorBaylor Research InstituteRan2021 to 2024Enrolled40ConditionsDiabetes, Diabetes Mellitus, Glucose, High Blood, Glucose, Low BloodArmsDexcom Generation 6 CGM (Dexcom Gen6) device
NCT06141941 nacompletednot on this mapstarted 2021, after this paper: background citation

Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes

TypeinterventionalSponsorUniversity of IowaRan2021 to 2024Enrolled39ConditionsPregestational DiabetesArmsCGM
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Accuracy of Continuous Glucose Monitors for Inpatient Diabetes Management.Journal of diabetes science and technology · 2023
    Article
  13. Article
  14. Stress and human health in diabetes: A report from the 19Journal of clinical and translational science · 2023
    Article
  15. Article
  16. Hospital Diabetes Meeting 2022.Journal of diabetes science and technology · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Elias K Spanakis1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-9352-7172
David L Levitt1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Tariq Siddiqui1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Lakshmi G Singh2 Division of Endocrinology, Baltimore Veterans Administration Medical Center, Baltimore, MD, USA.
Lillian Pinault2 Division of Endocrinology, Baltimore Veterans Administration Medical Center, Baltimore, MD, USA.
John Sorkin1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Guillermo E Umpierrez3 Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, GA, USA.
Jeffrey C Fink1 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
University of Maryland, Baltimore · USUnited States Department of Veterans Affairs · USEmory University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ALICE S. RYAN · 2006 to 2026
$28.9M
Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D, TAYLOR, SIMEON I. · 2005 to 2019
$17.3M
Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosoclerosis (MIRACULOUS)R01HL127422 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI RAJAGOPALAN, SANJAY, WEIR, MATTHEW R. · 2016 to 2020
$3.0M
Care Coordination/Telehealth to address patient safety and poor outcomes in CKDR34DK102177 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI FINK, JEFFREY C · 2014 to 2015
$567k
Can a sick-day protocol improve outcomes in Chronic Kidney Disease?R18DK110955 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI FINK, JEFFREY C · 2016 to 2017
$567k
NCRR NIH HHS UL1 RR025008NHLBI NIH HHS R01 HL127422NIA NIH HHS P30 AG028747NIDDK NIH HHS P30 DK072488NIDDK NIH HHS P30 DK111024NIDDK NIH HHS R18 DK110955NIDDK NIH HHS R34 DK102177
6 · The paper itself

Abstract

backgroundFew studies have examined the use of continuous glucose monitoring (CGM) devices in the general wards. The aim of this pilot study was to examine whether CGM readings can be successfully transmitted from the bedside to a central monitoring device in the nursing station, and whether a glucose telemetry system can prevent hypoglycemic events.

methodsWe present pilot data on 5 consecutive insulin treated general medicine patients with type 2 diabetes (T2DM) whose glucose values were observed with CGM (DEXCOM) and the results were transmitted to a central nursing station monitoring system using DEXCOM Follow and Share 2 software. CGM alarms were set-up at glucose <85 mg/dl.

resultsDuration of CGM observation was 4.0 ± 1.6 days (mean ± SD). During CGM, the overall time spent within blood glucose (BG) target of 70-179 mg/dl was 64.68 ± 15% (mean ± SD), on hypoglycemia (<70 mg/dl) was 0.30% ± 0.39, and time spent on hyperglycemia (≥180 mg/dl) was 35.02% ± 15.5. Two patients had 3 actions of prevention of potential hypoglycemia (CGM BG <70 mg/dl for >20 minutes) captured by alarm. No patients had CGM glucose value <54 mg/dl.

conclusionsThis pilot study indicates that the use of CGM values in hospitalized patients can be successfully transmitted to a monitoring device in the nursing station, improving patient surveillance in insulin treated patients with diabetes.

Indexed as

AgedBlood GlucoseFemaleHumansHypoglycemiaMaleMiddle AgedPilot ProjectsTelemetryBlood GlucoseCGMcontinuous glucose monitoringglucose telemetryhypoglycemiainpatienttype 2 diabetes

Identifiers

PMID29237288
PMCPMC5761998
OpenAlexW2773772558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.